Gastrointestinal Stromal Tumours treated before and after the advent of c-kit immunostaining
<p>Abstract</p> <p>Background</p> <p>Recently developed immunohistochemical markers have revolutionised the classification of gastrointestinal stromal tumours (GISTs) whilst tyrosine kinase inhibitors (imatinib) have had a significant impact on the treatment of advanced...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | World Journal of Surgical Oncology |
Online Access: | http://www.wjso.com/content/9/1/44 |